NCT01244620 A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses Status TERMINATED Phase PHASE1
NCT01244061 A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider Status COMPLETED Phase PHASE4
NCT01243203 Smoking Cessation Program in the Preadmission Clinic: The Use of a Teachable Moment Status COMPLETED Phase NA
NCT01243151 Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia Status COMPLETED Phase PHASE1
NCT01241591 A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01240915 A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT01239745 Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer Status TERMINATED Phase N/A
NCT01238991 Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT01237327 Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT01236378 Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients Status COMPLETED Phase PHASE1
NCT01236365 Statins in Children With Type 1 Diabetes and Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT01234142 A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days Status COMPLETED Phase PHASE1
NCT01233284 Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma. Status COMPLETED Phase PHASE2
NCT01232556 A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy Status TERMINATED Phase PHASE3
NCT01230385 Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects Status COMPLETED Phase PHASE1
NCT01230177 Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A